Lawrence Mary Gilbert
Department of Ophthalmology, University of Minnesota, and Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.
Trans Am Ophthalmol Soc. 2004;102:321-40.
To evaluate the accuracy of two digital-video retinal imaging (DVRI) systems to detect diabetic retinopathy.
A prospective, masked, technology assessment was conducted for two DVRI systems at a tertiary care Veterans Affairs Medical Center. Group A (n = 151 patients) was imaged with a 640x480 resolution system and group B (n = 103 patients) with an 800x600 resolution system. Four retinal evaluations were performed on each patient: DVRI with undilated pupils using one imaging field (U-DVRI), DVRI with dilated pupils using three imaging fields (D-DVRI), dilated clinical examination, and Early Treatment Diabetic Retinopathy Study stereoscopic seven-field photography (ETDRS-P). Two analyses of accuracy were conducted, one using ETDRS-P as a "gold standard" (ETDRS-GS) and one using dilated clinical examination as a "gold standard" (C-GS).
For group A, using the ETDRS-GS, sensitivities of U-DVRI and D-DVRI were 0.66 and 0.66; specificities of U-DVRI and D-DVRI were 0.66 and 0.86. Using the C-GS, sensitivities of U-DVRI and D-DVRI were 0.79 and 0.80; specificities of U-DVRI and D-DVRI were 0.68 and 0.85. For group B, using the ETDRS-GS, sensitivities of U-DVRI and D-DVRI were 0.76 and 0.85; specificities of U-DVRI and D-DVRI were 0.45 and 0.80. Using the C-GS, sensitivities of U-DVRI and D-DVRI were 0.81 and 0.87; specificities of U-DVRI and D-DVRI were 0.45 and 0.69. For both groups, dilation significantly improved specificities.
The 800x600 resolution DVRI system offers an accurate method of detecting diabetic retinopathy, provided there is adequate pupillary dilation and three retinal images are taken. DVRI technology may help facilitate retinal screenings of growing diabetic populations.
评估两种数字视频视网膜成像(DVRI)系统检测糖尿病视网膜病变的准确性。
在一家三级医疗退伍军人事务医疗中心对两种DVRI系统进行了一项前瞻性、盲法技术评估。A组(n = 151例患者)使用分辨率为640x480的系统成像,B组(n = 103例患者)使用分辨率为800x600的系统成像。对每位患者进行了四项视网膜评估:使用一个成像视野的未散瞳数字视频视网膜成像(U-DVRI)、使用三个成像视野的散瞳数字视频视网膜成像(D-DVRI)、散瞳临床检查以及糖尿病视网膜病变早期治疗研究立体七视野摄影(ETDRS-P)。进行了两项准确性分析,一项以ETDRS-P作为“金标准”(ETDRS-GS),另一项以散瞳临床检查作为“金标准”(C-GS)。
对于A组,使用ETDRS-GS时,U-DVRI和D-DVRI的敏感度分别为0.66和0.66;U-DVRI和D-DVRI的特异度分别为0.66和0.86。使用C-GS时,U-DVRI和D-DVRI的敏感度分别为0.79和0.80;U-DVRI和D-DVRI的特异度分别为0.68和0.85。对于B组,使用ETDRS-GS时,U-DVRI和D-DVRI的敏感度分别为0.76和0.85;U-DVRI和D-DVRI的特异度分别为0.45和0.80。使用C-GS时,U-DVRI和D-DVRI的敏感度分别为0.81和0.87;U-DVRI和D-DVRI的特异度分别为0.45和0.69。两组中,散瞳均显著提高了特异度。
800x600分辨率的DVRI系统提供了一种检测糖尿病视网膜病变的准确方法,前提是瞳孔充分散大且拍摄三张视网膜图像。DVRI技术可能有助于促进对不断增长的糖尿病患者群体进行视网膜筛查。